Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine - Schwedt, Todd J.; Myers Oakes, Tina M.; Martinez, James M.; Vargas, Bert B.; Pandey, Hitendra N.; Pearlman, Eric M.; Richardson, Diane R.; Varnado, Oralee J.; Meyer, Michael Cobas; Goadsby, Peter J. (Journal of the neurological sciences, 2023)